Comparison of Repaglinide and Nateglinide in Combination with Mefformin: Response to Raskin et al. [12] (multiple letters)

Michelle A. Baron; Philip Raskin

doi:10.2337/diacare.26.12.3361

Comparison of Repaglinide and Nateglinide in Combination with Mefformin: Response to Raskin et al. [12] (multiple letters)

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	3361-3363
Number of pages	3
Journal	Diabetes care
Volume	26
Issue number	12
DOIs	https://doi.org/10.2337/diacare.26.12.3361
State	Published - Dec 2003

ASJC Scopus subject areas

Internal Medicine
Endocrinology, Diabetes and Metabolism
Advanced and Specialized Nursing

Access to Document

10.2337/diacare.26.12.3361

Cite this

@article{bb01550167b54ecc9179526fb22d4c82,

title = "Comparison of Repaglinide and Nateglinide in Combination with Mefformin: Response to Raskin et al. [12] (multiple letters)",

author = "Baron, {Michelle A.} and Philip Raskin",

year = "2003",

month = dec,

doi = "10.2337/diacare.26.12.3361",

language = "English (US)",

volume = "26",

pages = "3361--3363",

journal = "Diabetes care",

issn = "0149-5992",

publisher = "American Diabetes Association Inc.",

number = "12",

}

TY - JOUR

T1 - Comparison of Repaglinide and Nateglinide in Combination with Mefformin

T2 - Response to Raskin et al. [12] (multiple letters)

AU - Baron, Michelle A.

AU - Raskin, Philip

PY - 2003/12

Y1 - 2003/12

UR - http://www.scopus.com/inward/record.url?scp=0345707485&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0345707485&partnerID=8YFLogxK

U2 - 10.2337/diacare.26.12.3361

DO - 10.2337/diacare.26.12.3361

M3 - Letter

C2 - 14633839

AN - SCOPUS:0345707485

SN - 0149-5992

VL - 26

SP - 3361

EP - 3363

JO - Diabetes care

JF - Diabetes care

IS - 12

ER -

Comparison of Repaglinide and Nateglinide in Combination with Mefformin: Response to Raskin et al. [12] (multiple letters)

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this